JOURNEY 71422374Recalls & reported problems
Smith & Nephew, Inc. · JOURNEY UNI COCR FIXED BEARING FEMORAL SIZE 4 RIGHT MEDIAL/LEFT LATERAL · Class 2 · Implant
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 03596010627544), received between Mar 11, 2026 and Mar 11, 2026 — classified as 1 injury.
1 other recall cover devices cleared under the same FDA submission (K073175, K081351, K230653); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Damage to Ligament(s)1
- Deformity/ Disfigurement1
- Discomfort1
- Fall1
- Inadequate Osseointegration1
- Joint Laxity1
- Subluxation1
- Swelling/ Edema1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 11, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, AFTER TKA SURGERY HAD BEEN PERFORMED ON (B)(6) 2023, THE PATIENT EXPERIENCED INCREASED DISCOMFORT IN THE RIGHT KNEE JOINT AFTER A FALL AND AFTER IMPLANTATION OF ONE (1) JRNY UNI TIBIAL BASE RM/LL SZ 4, ONE (1) JUNI COCR FB FEM SZ 4 RM LL AND ONE (1) JOURNEY UNI TIBINRT S3-4RM/LL8MM. EVEN BEFORE THE EVENT, THE JOINT WAS NOT COMPLETELY SYMPTOM-FREE WITH SWELLING STATES. THIS ADVERSE EVENT WAS TREATED BY A REVISION SURGERY ON (B)(6) 2026, IN WHICH ONE (1) LGN REV TIBIA BASE SZ 6 RT, ONE (1) LGN RK/HK HEMI SZ 5-6 LL/RM 5MM, ONE (1) LGN PRESSFIT STEM 14MM X 120MM, ONE (1) LEGION PS NP FEM SZ 6 RT AND ONE (1) LGN PS HIGH FLEX XLPE SZ 5-6 9MM WERE IMPLANTED. INTRAOPERATIVELY SHOWED COMPLETE ANTERIOR CRUCIATE LIGAMENT RUPTURE. THE TOTAL KNEE HAS INCREASED LAXITY, WITHOUT THE ANTERIOR CRUCIATE LIGAMENT, THE FEMORAL CONDYLES ARE OFFSET MEDIALLY. THE POST-OPERATIVE IMAGE SHOWS THE CORRECT IMPLANT POSITION. CURRENT HEALTH STATUS OF PATIENT REMAINS UNKNOWN.
Patient problems: Damage to Ligament(s); Deformity/ Disfigurement; Discomfort; Fall; Inadequate Osseointegration; Joint Laxity; Subluxation; Swelling/ Edema
MAUDE report 24568310 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K073175, K081351, K230653. One submission often covers many models, so check the product and lot details in each record.
- Z-2621-2023 · Aug 31, 2023 · Open, Classifiedsmith&nephew LEGION OXINUM POSTERIOR STABILIZED NONPOROUS FERMOAL COMPONENT, SIZE 5N, LEFT, NARROW, REF 71421265; knee joint
Other PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- LinkSymphoKnee 880-307/21WALDEMAR LINK GmbH & Co. KG · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls2 reports
- Scorpio 73-3710Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls1 report
- Scorpio 73-3110Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls0 reports
- Arthrex® AR-503-TTTEArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall14 reports
- Arthrex® AR-503-TTTJArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall9 reports
- Arthrex® AR-503-TTTGArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- ENGAGE 1-10011-300Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- ENGAGE 1-10003-400Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall6 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.